You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
6 August 2026 - Swiss biotechnology company Roche (SIX: RO, ROG; OTCQX: RHHBY), in collaboration with subsidiary TIB MOLBIOL, announced on Thursday the launch of two new real-time PCR tests to help laboratories detect the Cyclospora cayetanensis para...
Olio Labs reveals study demonstrating AI-driven in vivo platform can predict clinical trial outcomes
6 August 2026 - Biotechnology company Olio Labs on Wednesday published research showing that its preclinical in vivo platform predicts human clinical trial outcomes ranging from gastrointestinal adverse events to cardiac toxicity.Rodent studies have ...
6 August 2026 - China-based biopharmaceutical company Innovent Biologics Inc (HKEX: 01801) announced on Wednesday that the first patient has been dosed in a pivotal study evaluating IBI363 (Takeda R&D code: TAK-928), a potential first-in-class PD...
5 August 2026 - Biopharmaceutical company Citius Oncology Inc (Nasdaq: CTOR), a subsidiary of Citius Pharmaceuticals Inc (Nasdaq: CTXR), on Wednesday reported continued commercial progress for LYMPHIR, with the number of new institutional accounts or...
5 August 2026 - Clinical-stage biopharmaceutical company Obsidian Therapeutics Inc (Nasdaq:OBX) on Wednesday announced enrolment of the first patient in the registration-enabling cohort of its Phase 1/2 Agni-01 study evaluating amsokigene autoleucel ...
5 August 2026 - Biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ: SMMT) reported on Wednesday that it has expanded the global clinical development programme for its investigational bispecific antibody ivonescimab by launching the Ph...
5 August 2026 - Sisram Medical Ltd (HK:1696), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, announced on Tuesday the official launch of its Titanium Prime treatment concept in Hong Kong S...